Microvascular determinants of cognitive decline and brain volume change in elderly patients with type 2 diabetes

Dementia and Geriatric Cognitive Disorders

Volumn 30, Issue 5, 2010, Pages 381-386

  De Bresser, Jeroen ^a,b   Reijmer, Yael D ^a   Van Den Berg, Esther ^a,d   Breedijk, Marja A ^c   Kappelle, L Jaap ^a   Viergever, Max A ^b   Biessels, Geert Jan ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Cerebral atrophy; Cerebral complications; Cognition; Magnetic resonance imaging, brain; Microvascular complications; Type 2 diabetes mellitus; White matter hyperintensities

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; AGED; ALBUMINURIA; ARTICLE; BRAIN SIZE; BRAIN VENTRICLE; COGNITION; COGNITIVE DEFECT; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE DURATION; ELDERLY CARE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN TREATMENT; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MICROVASCULARIZATION; NEUROIMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; REGRESSION BASED INDEX; SCORING SYSTEM; VOLUMETRY; WHITE MATTER;

AGED; AGED, 80 AND OVER; ALBUMINURIA; ATROPHY; BRAIN; CAPILLARIES; CEREBRAL INFARCTION; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 77958021269     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321354     Document Type: Article

References (18)

1. Biessels GJ, Deary IJ, Ryan CM: Cognition and diabetes: a lifespan perspective. Lancet Neurol 2008; 7: 184-190.
2. Manschot SM, Brands AM, van der Grond J, Kessels RP, Algra A, Kappelle LJ, Biessels GJ: Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 2006; 55: 1106-1113.
3. Weiner DE, Bartolomei K, Scott T, Price LL, Griffith JL, Rosenberg I, Levey AS, Folstein MF, Sarnak MJ: Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders. Am J Kidney Dis 2009; 53: 438-447.
4. Wong TY, Mosley TH Jr, Klein R, Klein BE, Sharrett AR, Couper DJ, Hubbard LD: Retinal microvascular changes and MRI signs of cerebral atrophy in healthy, middle-aged people. Neurology 2003; 61: 806-811.
5. de Bresser J, Tiehuis AM, van den Berg E, Reijmer YD, Jongen C, Kappelle LJ, Mali WP, Viergever MA, Biessels GJ: Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes. Diabetes Care 2010; 33: 1309-1314.
6. van den Berg E, Reijmer YD, de Bresser J, Kessels RP, Kappelle LJ, Biessels GJ: A 4-year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia 2010; 53: 58-65.
7. Lezak MD, Howieson DB, Loring DW: Neuropsychological assessment, ed 4th. New York, Oxford University Press, 2004.
8. Temkin NR, Heaton RK, Grant I, Dikmen SS: Detecting significant change in neuropsychological test performance: a comparison of four models. J Int Neuropsychol Soc 1999; 5: 357-369.
9. Anbeek P, Vincken KL, van Bochove GS, van Osch MJ, van der Grond J: Probabilistic segmentation of brain tissue in MR imaging. Neuroimage 2005; 27: 795-804.
10. Anan F, Masaki T, Iwao T, Eto T, Shimomura T, Umeno Y, Eshima N, Saikawa T, Yoshimatsu H: The role of microalbuminuria and insulin resistance as significant risk factors for white matter lesions in Japanese type 2 diabetic patients. Curr Med Res Opin 2008; 24: 1561-1567.
11. Bruce DG, Davis WA, Casey GP, Starkstein SE, Clarnette RM, Almeida OP, Davis TM: Predictors of cognitive decline in older individuals with diabetes. Diabetes Care 2008; 31: 2103-2107.
12. de Luis DA, Fernandez N, Arranz M, Aller R, Izaola O: Total homocysteine and cognitive deterioration in people with type 2 diabetes. Diabetes Res Clin Pract 2002; 55: 185-190.
13. Manschot SM, Biessels GJ, de Valk H, Algra A, Rutten GE, van der Grond J, Kappelle LJ: Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia 2007; 50: 2388-2397.
14. Wessels AM, Simsek S, Remijnse PL, Veltman DJ, Biessels GJ, Barkhof F, Scheltens P, Snoek FJ, Heine RJ, Rombouts SA: Voxelbased morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia 2006; 49: 2474-2480.
15. Schmieder RE, Schrader J, Zidek W, Tebbe U, Paar WD, Bramlage P, Pittrow D, Bohm M: Low-grade albuminuria and cardiovascular risk: what is the evidence? Clin Res Cardiol 2007; 96: 247-257.
16. Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, Parving HH: Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 2002; 51: 1157-1165.
17. Rozzini L, Chilovi BV, Bertoletti E, Conti M, Del Rio I, Trabucchi M, Padovani A: Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment. Int J Geriatr Psychiatry 2006; 21: 550-555.
18. Khachaturian AS, Zandi PP, Lyketsos CG, Hayden KM, Skoog I, Norton MC, Tschanz JT, Mayer LS, Welsh-Bohmer KA, Breitner JC: Antihypertensive medication use and incident Alzheimer disease: The Cache County study. Arch Neurol 2006; 63: 686-692.